Pfizer makes a $4.9 billion bet on obesity drugs with Metsera buyout dealBy Mario Cazombo / September 22, 2025 Metsera’s shareholders could see significant bonuses if certain milestones are reached.
Book Review: The Financial Restructuring Tool Set August 6, 2025 / Book Reviews, Corporate Finance, Drivers of Value, Economics, Financial Statement Analysis, General
